Studies have shown that active fund managers routinely underperform the S&P500 index*​

Seaport Therapeutics, Inc. (NASDAQ: SPTX)

SPTX Stock Predictions and Ratings

WSX Rating:
NOT AVAILABLE
WSX Forecast (1yr):
NOT AVAILABLE
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
112.80%

SPTX Stock Analysis

SPTX PE Ratio:

SPTX PEG Ratio: Not Available

SPTX Forward EPS Growth (12 month): 0.00%

SPTX PS Ratio:

SPTX PSG Ratio: Not Available

SPTX Forward Revenue Growth (12 month): 0.00%

SPTX Articles

No data was found